Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
837.9 INR | -2.45% | +2.80% | +29.06% |
May. 23 | Strides Pharma Science Turns to Consolidated Net Profit in Fiscal Q4; Shares Down 3% | MT |
May. 22 | Transcript : Strides Pharma Science Limited, Q4 2024 Earnings Call, May 22, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+29.06% | 950M | |
+13.53% | 41.95B | |
+22.20% | 22.53B | |
+15.11% | 14.91B | |
+17.35% | 14.11B | |
+45.62% | 12.5B | |
-9.44% | 6.75B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.55% | 5.6B |
- Stock Market
- Equities
- STAR Stock
- News Strides Pharma Science Limited
- Strides Pharma Arm Gets US FDA's Approval for Generic Drug for Hypocalcemia